Nasrin Haghani: Vitamin D and Omega-3 Fatty Acids May Support Mood Regulation
Nasrin Haghani, Surgical Lead Technician at Nuvia Dental Implant Center, shared on LinkedIn:
“Recent research has explored the role of nutrition in mental health, finding that vitamin D and omega-3 fatty acids may significantly support mood regulation. Both nutrients play important biological roles in brain function. Vitamin D influences neurotransmitters such as serotonin, which affects mood stability, while omega-3 fatty acids help maintain the structure of brain cell membranes and support communication between neurons. When levels of these nutrients are low, mood disorders such as depression may become more likely or more severe.
Some clinical studies suggest that supplementation with vitamin D and omega-3s can improve depressive symptoms in certain individuals, particularly those who are deficient. Omega-3 fatty acids, especially EPA and DHA, have been shown to reduce inflammation in the brain, a factor increasingly linked to mood disorders. Vitamin D also supports immune balance and hormonal regulation, which may indirectly influence emotional well-being. These mechanisms help explain why improvements in mood have been observed in some controlled trials when nutritional deficiencies are corrected.
It is important to note that these nutrients are not universal replacements for antidepressant medications, especially in moderate to severe cases. Instead, they may serve as supportive tools within a broader treatment plan that includes professional care, therapy, and healthy lifestyle habits. Balanced nutrition, sunlight exposure, and medical guidance together create a more comprehensive approach to long-term mental health support.”

Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis